Cyclin D1 and pancreatic carcinoma: A proliferative agonist and chemotherapeutic antagonist

被引:13
作者
Diehl, JA [1 ]
Benzeno, S [1 ]
机构
[1] Univ Penn, Leonard & Madlyn Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA
关键词
D O I
10.1158/1078-0432.CCR-05-1016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:5665 / 5667
页数:3
相关论文
共 20 条
[1]   Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation [J].
Alt, JR ;
Cleveland, JL ;
Hannink, M ;
Diehl, JA .
GENES & DEVELOPMENT, 2000, 14 (24) :3102-3114
[2]   Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line [J].
Biliran, H ;
Wang, Y ;
Banerjee, X ;
Xu, HM ;
Heng, H ;
Thakur, A ;
Bollig, A ;
Sarkar, FH ;
Liao, JD .
CLINICAL CANCER RESEARCH, 2005, 11 (16) :6075-6086
[3]   Emerging roles for E2F: Beyond the G1/S transition and DNA replication [J].
Cam, H ;
Dynlacht, BD .
CANCER CELL, 2003, 3 (04) :311-316
[4]   Glycogen synthase kinase 3β regulates cyclin D1 proteolysis and subcellular localization [J].
Diehl, JA ;
Cheng, MG ;
Roussel, MF ;
Sherr, CJ .
GENES & DEVELOPMENT, 1998, 12 (22) :3499-3511
[5]  
Fry DW, 2004, MOL CANCER THER, V3, P1427
[6]  
Guttridge DC, 1999, MOL CELL BIOL, V19, P5785
[7]   The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2 [J].
Kitagawa, M ;
Higashi, H ;
Jung, HK ;
SuzukiTakahashi, I ;
Ikeda, M ;
Tamai, K ;
Kato, J ;
Segawa, K ;
Yoshida, E ;
Nishimura, S ;
Taya, Y .
EMBO JOURNAL, 1996, 15 (24) :7060-7069
[8]  
Korc M, 1998, Surg Oncol Clin N Am, V7, P25
[9]  
Kornmann M, 1999, CANCER RES, V59, P3505
[10]   Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum [J].
Kornmann, M ;
Arber, N ;
Korc, M .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :344-352